Earendil: A Blueprint for a Multipolar Life Sciences Era
The $787M financing points to a new global architecture in biotech
False
The $787M financing points to a new global architecture in biotech
False
False
February 3, 2025
4 min read
With new cases of avian influenza appearing, what does this mean for global health and what are drug developers doing about it?
December 1, 2014
2 min read
Can phage endolysins revolutionize the way bacterial infections are treated – and prevent drug resistance?
April 2, 2025
2 min read
How fluid flow through the body can affect the ways in which antibiotics work.
April 7, 2025
4 min read
Celon Pharma CEO hopes their new compound could be a potential breakthrough for Parkinson’s patients.
False
Affiliations:
Specialties:
Areas of Expertise:
4 Topic Commentaries
Earendil: A Blueprint for a Multipolar Life Sciences Era
Julio Frenk, MD, MPH, PhD
Global health policy and health systems
•Harvard University
Nalini Anand, JD, MPH
Global health policy and research administration
•Georgetown University
Andrew Forsyth, PhD
Global health research policy and analytics
•Fogarty International Center, National Institutes of Health
Cassidy R. Sugimoto, PhD
Science of science and science policy
•Georgia Institute of Technology
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.